Every material Form 8-K Amesite Inc. has filed with the SEC since July 20, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Amesite Inc. said its next annual stockholder meeting will be held on December 10, 2026, moved from the July 13, 2026 meeting date. The company set September 27, 2026 as the deadline for stockholder proposals and director nominations, and October 13, 2026 as the deadline for universal proxy notices, so shareholders who want to act at the meeting have specific dates to meet.
Annual meeting set for Thursday, December 10, 2026; prior annual meeting was held July 13, 2026
Rule 14a-8 proposal deadline for the proxy statement is close of business September 27, 2026
Advance notice deadline for nominations or other proposals is September 27, 2026
Universal proxy notice under Rule 14a-19 is due October 13, 2026
Amesite Inc. (Nasdaq: AMST) furnished presentation materials under Regulation FD for use at the H.C. Wainwright 28th Annual Global Investment Conference, held September 14 through September 16, 2026. The filing is an administrative disclosure of investor materials and does not report new financial results, guidance, or transactions.
Presentation materials dated September 9, 2026 are furnished as Exhibit 99.1.
The conference is the H.C. Wainwright 28th Annual Global Investment Conference, September 14 to September 16, 2026.
The materials show a $2.9 million cash balance and no debt, as of the April 28, 2026 post-fundraise slide, along with a $2.6 million April 2026 capital raise at $1.435 per share.
On July 17, 2026, Amesite entered an At The Market Offering Agreement with H.C. Wainwright & Co. under which it may sell common stock through the agent from time to time, up to a maximum amount defined in the agreement. The filing says the company is not obligated to sell any shares, and that proceeds, if any, would go to general corporate and working capital purposes; sales would dilute existing shareholders, though the filing does not quantify the share count or total proceeds.
Agreement dated July 17, 2026, with H.C. Wainwright & Co., LLC as sales agent
Agent commission of 3.0% of gross proceeds from each share sale, plus legal fee reimbursement capped at $50,000
Shares to be sold under a Form S-3 shelf registration (File No. 333-282999) effective December 18, 2024
No obligation to sell any shares; the filing gives no amount or timing for sales
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Amesite Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →